Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2
Bob W. van Oosten(Amsterdam Neuroscience), C. Polman, Jan Boringa(Alrijne Ziekenhuis), Hans‐Peter Hartung(The University of Sydney), Frederik Barkhof(National Hospital for Neurology and Neurosurgery), B. Mary E. von Blomberg(Vrije Universiteit Amsterdam), J. Woody, L. Truyen(Amsterdam UMC Location Vrije Universiteit Amsterdam), Frits W. Bertelsmann(Amsterdam UMC Location Vrije Universiteit Amsterdam)
Cited by 733
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis
|Annals of Neurology|2001|7k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”
|Annals of Neurology|2005|5k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k